AI pharmaceutical "new star" favored by top venture capital Thrive Capital and OpenAI.

AI pharmaceutical startup Chai Discovery raised nearly $30 million in its latest seed round of financing, with investors including well-known investment firms Thrive Capital and OpenAI. The company's goal is to transform biology from a science to engineering through AI technology, making the drug development process more efficient. The company released its first open-source molecular structure model, Chai-1, on Monday, outperforming Google's AlphaFold and ESM3. In the AI drug development field, Chai faces competition from other startups and tech giants like Google, the latter predicting the market size to potentially exceed $100 billion.

wallstreetcn12:52 ET

Truist Financial Maintains Absci Corp(ABSI.US) With Buy Rating

Moomoo NewsSep 3 07:31 ET · Ratings

Absci Corporation (ABSI): A Penny Stock That Will Make You a Millionaire

Yahoo FinanceAug 31 14:37 ET

Absci to Participate in Upcoming Investor Conferences

GlobeNewswireAug 21 08:00 ET

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Earnings Call TranscriptsAug 16 23:50 ET

Express News | Absci Shares Are Trading Higher. The Company Reported Q2 Financial Results

BenzingaAug 15 10:45 ET